Insiders · Profile

Megna Michael R

CHIEF ACCOUNTING OFFICER at Kiniksa Pharmaceuticals International. Filing since 19 Dec 2023. CIK 0001464583

Company
Date
Role
Action
Shares
Amount
Of holding
3 Sep 2026
CHIEF ACCOUNTING OFFICER
Sold on a plan
4,600
$369.38K
13.7%
9 Apr 2026
CHIEF ACCOUNTING OFFICER
Sold on a plan
6,625
$309.32K
19.5%
20 Oct 2025
CHIEF ACCOUNTING OFFICER
Sold on a plan
50,490
$1.96M
65.1%
3 Sep 2025
CHIEF ACCOUNTING OFFICER
Sold on a plan
11,000
$383.24K
22.4%
4 Aug 2025
CHIEF ACCOUNTING OFFICER
Sold on a plan
17,000
$549.95K
34.0%
3 Jun 2025
CHIEF ACCOUNTING OFFICER
Sold on a plan
15,211
$437.32K
31.9%
7 May 2025
CHIEF ACCOUNTING OFFICER
Sold on a plan
17,647
$471.00K
35.2%
12 Mar 2025
CHIEF ACCOUNTING OFFICER
Sold on a plan
9,051
$203.19K
25.4%
29 Nov 2024
CHIEF ACCOUNTING OFFICER
Sold on a plan
9
$202.05
0.0%
27 Nov 2024
CHIEF ACCOUNTING OFFICER
Sold on a plan
8,637
$193.90K
24.6%
1 Mar 2024
CHIEF ACCOUNTING OFFICER
Sold on a plan
9,659
$207.19K
35.4%
28 Feb 2024
CHIEF ACCOUNTING OFFICER
Sold on a plan
5,126
$111.70K
22.6%
2 Jan 2024
CHIEF ACCOUNTING OFFICER
Sold on a plan
16,670
$319.56K
49.5%
19 Dec 2023
CHIEF ACCOUNTING OFFICER
Sold on a plan
9,316
$178.22K
35.4%
14 decisions on file.